Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DnaJ heat shock protein family member C16 (DNAJC16) is a protein-coding gene and member of the Hsp40 (DnaJ) co-chaperone family primarily localized in the endoplasmic reticulum membrane[1][3]. It plays a key role in the regulation of autophagosome size during autophagy and functions as a molecular chaperone involved in protein quality control within the ER. DNAJC16 is expressed in multiple tissues, showing selective marker properties in nervous system cell types such as glial cells, cerebellar granule cells, and astrocytes[4]. There is currently no evidence that DNAJC16 is a direct therapeutic target, nor are there known drugs interacting with this protein or specific disease roles beyond a genetic association with prostatic cyst[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DnaJ heat shock protein family member C16 (DNAJC16).